Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment
Conventional anti-cancer therapy involves the use of chemical chemotherapeutics and radiation and are often non-specific in action. The development of drug resistance and the inability of the drug to penetrate the tumor cells has been a major pitfall in current treatment. This has led to the investi...
Main Authors: | Shruti S. Sawant, Suyash M. Patil, Vivek Gupta, Nitesh K. Kunda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7575 |
Similar Items
-
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy
by: Kajal H. Gupta, et al.
Published: (2021-12-01) -
Editorial: Microorganisms and their derivatives for cancer therapy
by: Yunlei Zhang, et al.
Published: (2023-01-01) -
Hydrogels as promising platforms for engineered living bacteria-mediated therapeutic systems
by: Shuangjiang Yu, et al.
Published: (2022-12-01) -
Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity
by: Qichao Yang, et al.
Published: (2022-07-01) -
Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment
by: Anna-Lena Mueller, et al.
Published: (2022-04-01)